# SkillCertify — Cycle Review Public Summary Candidate

Task: task.skillcertify.10.011
Stage: stage.skillcertify.10

Publication disposition: private_ready
Public-safe determination: not yet performed
Publication authorized: false
Publication performed: false

## Purpose

This document is a minimal, repository-native derivative of the frozen Stage 10
Cycle Review evidence.

It is intentionally narrower than the underlying evidence set.

It does not copy internal approval sidecars, raw structured evidence, local
filesystem paths, governance implementation details, confidential career
material or future-product planning decisions.

This file is prepared for later human review and possible publication
authorization.

`private_ready` does not mean `public-safe`.

## 1. Evidence discipline

The Cycle Review uses bounded evidence rules.

Repository presence, dependency declarations, workflow files, scripts or test
files are not treated by themselves as proof that execution succeeded.

Execution claims are limited to evidence directly qualified for the relevant
claim type.

Missing evidence is preserved as unknown rather than converted into a verified
negative result.

## 2. Technical evidence baseline

At the qualified technical baseline:

- 238 tracked repository files were represented;
- 24 documented execution-evidence candidates were reviewed;
- 9 candidates were promoted as bounded direct execution evidence;
- 15 candidates were not promoted.

These counts describe evidence classification inside the reviewed repository
baseline.

They do not establish universal execution success or production readiness.

## 3. Verified retrospective scope

The planning identity referenced a 90-day retrospective, but the verified
evidence window was narrower.

Verified evidence coverage:

- start: 2026-08-21T19:51:40-03:00
- end: 2026-09-07T14:48:11-03:00
- verified duration: approximately 16.79 days

Accordingly, the review does not claim 90 days of factually verified historical
coverage.

Activity outside the verified evidence window remains unknown unless supported
by separately admitted evidence.

## 4. Bounded code-quality findings

Two qualified quality-control evidence points used a common repository-native
chain including lint, type checking, tests and build validation.

Across those two qualified points:

- the common quality chain remained green;
- the regression suite remained 26 of 26 passing;
- the later clean-checkout / CI evidence exposed two reproducibility defects
  that were corrected before final green evidence;
- the later CI evidence also established positive, deliberate negative and
  restored-green remote execution paths.

These findings support a bounded chronology of quality-control and
reproducibility evidence.

They do not establish:

- a percentage improvement in code quality;
- a reduction in defect rate;
- improved code coverage;
- a causal quality improvement;
- a long-term quality trend;
- production readiness.

The qualified comparison window was approximately six hours and must not be
generalized beyond that scope.

## 5. Deferred DORA measurement

A DORA metrics proof of concept was deferred in the reviewed cycle.

The qualified evidence did not establish directly verifiable operational event
series sufficient for any of the four DORA metric families considered:

- deployment frequency;
- lead time for changes;
- change failure rate;
- time to restore service.

The review therefore did not manufacture DORA metrics from non-equivalent
repository signals.

Examples of prohibited substitutions include:

- merge count as deployment frequency;
- CI runs as production deployments;
- failed tests as change failures;
- build failures as production incidents.

The defer decision is bounded to the current evidence state and does not mean a
future DORA evaluation is permanently ineligible.

## Claim boundaries

This derivative intentionally does not publish or infer:

- employment-funnel conversion rates;
- screening, interview, rejection or offer rates;
- hiring effectiveness;
- individual candidate or recruiter information;
- product analytics instrumentation decisions in detail;
- local filesystem paths;
- approval hashes or internal governance sidecars;
- internal tool-selection heuristic scores;
- confidential decision text;
- Strategy or WIP state;
- future ClinicFlow outcome planning;
- ClinicFlow execution;
- production readiness;
- universal PASS;
- causal product or code-quality claims.

## Source evidence

This derivative was prepared from frozen Stage 10 evidence including:

- `stage10-evidence/10-003/TECHNICAL_REPOSITORY_INVENTORY.md`
- `stage10-evidence/10-004/RETROSPECTIVE_90_DAY_REPORT.md`
- `stage10-evidence/10-006/CODE_QUALITY_TREND_REPORT.md`
- `stage10-evidence/10-007/DORA_POC_DEFER_REPORT.md`

Additional Stage 10 evidence was inspected for exclusion boundaries and
provenance but is not reproduced here.

## Publication boundary

Current status: `private_ready`.

This file has not been declared `public-safe`.

No secret scanner has been executed for this derivative.

No external publication is authorized.

Human review remains required before any future publication decision.

Publication, if ever approved, remains a separate governed action.
